HALF OF WOMEN WITH EARLY BREAST CANCER STOP ENDOCRINE THERAPY BEFORE FIVE YEARS: RESULTS FROM AN AUSTRALIAN POPULATION-BASED STUDY

QR Code

HALF OF WOMEN WITH EARLY BREAST CANCER STOP ENDOCRINE THERAPY BEFORE FIVE YEARS: RESULTS FROM AN AUSTRALIAN POPULATION-BASED STUDY

Bibliographic Details
Main Authors:	Kemp, A., Roughead, E., Saunders, C., Boyle, F., Bulsara, M., Malacova, Eva, Preen, D.
Format:	Conference Paper
Published:	2014
Online Access:	http://hdl.handle.net/20.500.11937/57739

Similar Items

Early discontinuation of endocrine therapy for breast cancer: Who is at risk in clinical practice?
by: Kemp, A., et al.
Published: (2014)

Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: The impact of comorbidity and demographics on initial choice
by: Kemp, A., et al.
Published: (2014)

Endocrine therapy for breast cancer: a model of hormonal manipulation
by: Johnston, Simon J., et al.
Published: (2018)

Optimising endocrine therapy in postmenopausal women with advanced breast cancer
by: Yau, Thomas Ho Lai, et al.
Published: (2018)

Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer
by: Alfarsi, Lutfi, et al.
Published: (2018)

Development of a clinically relevant subclassification of luminal breast cancer related to response to endocrine therapy
by: Alfarsi, Lutfi
Published: (2020)

Investigating extracellular vesicle communication in the endocrine cancers of the prostate and breast
by: Brown, Thomas J.
Published: (2024)

Cost-effectiveness of primary endocrine therapy comparing against surgery as the initial treatment strategy in older women with primary breast cancer
by: Mousa, Rimal
Published: (2017)

Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: a structural approach
by: Etti, Imaobong C., et al.
Published: (2024)

Have increases in co-payments for medicines further burdened Australians in remote and disadvantaged areas?
by: Kemp, A., et al.
Published: (2012)

From the city to the bush: Increases in patient co-payments for medicines have impacted on medicine use across Australia
by: Kemp, A., et al.
Published: (2013)

Antiproton stopping power data for radiation therapy simulations
by: Bailey, Jackson, et al.
Published: (2016)

Effectiveness of in vitro fertilization in women with previous tubal sterilization
by: Malacova, Eva, et al.
Published: (2015)

Long-term risk of ectopic pregnancy varies by method of tubal sterilization: A whole-population study
by: Malacova, Eva, et al.
Published: (2014)

Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer
by: Wolff, A., et al.
Published: (2013)

Endocrine control of oogenesis in teleosts
by: Fard, Ehsan Ramezani, et al.
Published: (2013)

The truth, the half-truth, and nothing like the truth: reconceptualizing false allegations of rape
by: Saunders, Candida L.
Published: (2012)

Rates of reoperation after breast conserving cancer surgery in Western Australia before and after publication of the SSO-ASTRO margins guideline.
by: Marinovich, Luke, et al.
Published: (2023)

Half circle position for arc cracks in half plane
by: Elfakhakhre, Nawara R. F., et al.
Published: (2018)

Early stopping turbo iteration at low SNR for CE-based stopping criteria
by: Mohamad, Roslina, et al.
Published: (2014)

Unexpected ovarian malignancy after conservative laparoscopic surgery: ﬁve case series in a half decade of experience
by: Abd. Wahab, Noraziana, et al.
Published: (2012)

How much do we spend on prescription medicines?: Out-of-pocket costs for patients in Australia and other OECD countries
by: Kemp, A., et al.
Published: (2011)

Impact of cost of medicines for chronic conditions on low income households in Australia
by: Kemp, A., et al.
Published: (2013)

Determinants of self-reported medicine underuse due to cost: a comparison of seven countries
by: Kemp, A., et al.
Published: (2010)

Cervical spondylotic radiculopathy: Early result from a conservative therapy
by: Zakaria@Mohamad, Zamzuri, et al.
Published: (2019)

In vitro fertilization and breast cancer: Is there cause for concern?
by: Stewart, L., et al.
Published: (2012)

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
by: Cameron, David, et al.
Published: (2013)

The impact of co-payment increases on dispensings of government-subsidised medicines in Australia
by: Hynd, A., et al.
Published: (2008)

Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia
by: Hynd, A., et al.
Published: (2009)

Stop That Weed!
by: Kiew, R., et al.
Published: (2016)

Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial
by: Ormerod, Anthony D., et al.
Published: (2015)

A job half done?
by: Leslie, Gavin
Published: (2008)

Evaluating pharmaceutical policy impacts using interrupted time series analysis: An Australian case study
by: Kemp, A., et al.
Published: (2011)

EU regulation of endocrine disruptors: a missed opportunity
by: Kortenkamp, Andreas, et al.
Published: (2016)

Effects of lindane as an endocrine disruptor chemical on human health
by: Rozita, H.,, et al.
Published: (2005)

Ciclosporin compared to prednisolone therapy for patients with pyoderma gangrenosum: cost-effectiveness analysis of the STOP GAP trial
by: Mason, J.M., et al.
Published: (2017)

PEG-PLA Nanoformulation for Breast Cancer Therapy
by: Kannapiran, Sushma, et al.
Published: (2022)

Stopping human trafficking
by: Ab Hamid, Zuraini
Published: (2017)

No stopping Keris Conlay
by: New Straits Times,
Published: (2017)

Stop Abusing the Unborn
by: Abd Razak, Dzulkifli
Published: (1995)